• bitcoinBitcoin(BTC)$64,505.000.00%
  • ethereumEthereum(ETH)$1,804.980.56%
  • tetherTether(USDT)$1.00-0.04%
  • binancecoinBNB(BNB)$589.400.15%
  • usd-coinUSDC(USDC)$1.000.00%
  • rippleXRP(XRP)$0.95-0.39%
  • solanaSolana(SOL)$70.680.17%
  • tronTRON(TRX)$0.302618-1.17%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.06-0.87%
  • HyperliquidHyperliquid(HYPE)$66.021.00%
  • zcashZcash(ZEC)$888.14-0.96%
  • dogecoinDogecoin(DOGE)$0.0584371.00%
  • moneroMonero(XMR)$485.980.14%
  • USDSUSDS(USDS)$1.000.00%
  • leo-tokenLEO Token(LEO)$9.170.55%
  • whitebitWhiteBIT Coin(WBT)$62.45-0.02%
  • chainlinkChainlink(LINK)$9.100.06%
  • RainRain(RAIN)$0.008672142.17%
  • cardanoCardano(ADA)$0.1520321.29%
  • Ethena USDeEthena USDe(USDE)$1.000.00%
  • stellarStellar(XLM)$0.137541-0.35%
  • daiDai(DAI)$1.000.01%
  • nearNEAR Protocol(NEAR)$3.171.47%
  • bitcoin-cashBitcoin Cash(BCH)$206.351.10%
  • litecoinLitecoin(LTC)$44.54-0.37%
  • CantonCanton(CC)$0.0833994.55%
  • avalanche-2Avalanche(AVAX)$7.12-0.13%
  • uniswapUniswap(UNI)$5.143.24%
  • tether-goldTether Gold(XAUT)$3,840.740.60%
  • USD1USD1(USD1)$1.000.05%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.050.99%
  • suiSui(SUI)$0.720.52%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • Global DollarGlobal Dollar(USDG)$1.000.01%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.01%
  • hedera-hashgraphHedera(HBAR)$0.0582762.36%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.10%
  • shiba-inuShiba Inu(SHIB)$0.000004-0.16%
  • quant-networkQuant(QNT)$155.407.24%
  • BittensorBittensor(TAO)$188.740.93%
  • crypto-com-chainCronos(CRO)$0.042307-2.45%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.12-0.08%
  • MemeCoreMemeCore(M)$0.822.29%
  • okbOKB(OKB)$85.19-0.96%
  • pax-goldPAX Gold(PAXG)$3,844.040.62%
  • aaveAave(AAVE)$108.473.46%
  • Falcon USDFalcon USD(USDF)$1.000.05%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • United StablesUnited Stables(U)$1.00-0.04%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Flagship Pioneering Launches London Lab to Build AI-Native Companies – Unite.AI

November 16, 2026
in AI & Technology
Reading Time: 2 mins read
A A
Flagship Pioneering Launches London Lab to Build AI-Native Companies – Unite.AI
ShareShareShareShareShare

Flagship Pioneering announced on November 16, 2026 that it is establishing Flagship Origination Lab, U.K. in London, backed by an initial £100 million commitment. The lab will conceive, test, fund and build AI-native platform companies, and is Flagship’s first dedicated company-creation unit outside the United States.

YOU MAY ALSO LIKE

Apple’s New Research App Is Designed To Make AI Health Tools More User-Friendly

APA Issues Workplace AI Guidance on Trust, Oversight and Job Design – Unite.AI

Operating within Flagship Labs, the London unit will focus on human and planetary health and other frontiers of science and technology. It brings a company-creation model developed in Cambridge, Massachusetts, into a locally rooted UK ecosystem connected to Flagship’s global organization.

Founder and CEO Noubar Afeyan said Flagship anticipates scaling its commitment through partnerships to attract an additional £500 million. The additional amount depends on future partnerships and remains separate from the capital committed at launch.

A UK Team for Company Origination

Flagship expects to recruit and train approximately 50 scientist-entrepreneurs and operators for the initial UK team. The local company-creation ecosystem will remain connected to the broader organization, including its Pioneering Intelligence and Pioneering Medicines business units.

Flagship’s model starts with scientific questions and develops them into platforms, products and companies. The firm says it has created more than 130 companies over more than 25 years, including Moderna, providing the company-creation record it is now extending to the UK.

Avak Kahvejian, president of Flagship Labs and a general partner at Flagship Pioneering, described origination as a discipline led by teams of scientist-entrepreneurs who “begin with bold questions about what could be possible.” The London team will accordingly be involved in generating and testing ideas as well as financing and building the resulting companies.

That structure gives Flagship a role from the earliest stage of company formation. Rather than operating solely as an investor in existing startups, the lab is designed to originate the underlying scientific platforms and then build businesses around them within its own ecosystem.

The UK Foundation for the Expansion

The launch follows three years of Flagship partnering and conducting R&D across the UK. It opened a London office and signed a memorandum of understanding with the UK government in 2023 to extend the global reach and impact of its companies.

Flagship describes Quotient Therapeutics, launched during that period, as its first transatlantic company. Its UK activity also includes clinical trials involving Flagship-founded companies such as Generate:Biomedicines, alongside partnerships across academia, data and regulatory innovation.

Kahvejian said the UK’s science base, clinical-trial infrastructure, genomics and health-data assets, agile regulatory environment, and scientists and entrepreneurs made it a deliberate choice for the expansion. Those resources provide the foundation on which Flagship intends to build its local company-creation operation.

Chris McDonald MP, Minister for Science, Innovation and Investment, said the government wants more AI and life-sciences businesses to turn research and technology into jobs and economic growth, with Flagship’s commitment helping new UK companies take breakthroughs to international markets.

The expansion adds local company origination to Flagship’s existing UK research, partnerships and clinical activity. Its larger financial ambition depends on attracting partners, while the lab’s operational test is whether the new team can turn those scientific and clinical assets into new AI-native companies.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Apple’s New Research App Is Designed To Make AI Health Tools More User-Friendly
AI & Technology

Apple’s New Research App Is Designed To Make AI Health Tools More User-Friendly

November 16, 2026
APA Issues Workplace AI Guidance on Trust, Oversight and Job Design – Unite.AI
AI & Technology

APA Issues Workplace AI Guidance on Trust, Oversight and Job Design – Unite.AI

November 16, 2026
ULA Vulcan Rocket Failure Destroys 40 Amazon Leo Satellites
AI & Technology

ULA Vulcan Rocket Failure Destroys 40 Amazon Leo Satellites

November 16, 2026
AI-Guided Echocardiography Shows High Yield in Controlled Studies – Unite.AI
AI & Technology

AI-Guided Echocardiography Shows High Yield in Controlled Studies – Unite.AI

November 16, 2026
Next Post
BK Technologies: A Temporary Setback And Less Visibility (Rating Downgrade)

BK Technologies: A Temporary Setback And Less Visibility (Rating Downgrade)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Where to Donate Used Toys – 16 Places That Take What Toy Drives Won’t

Where to Donate Used Toys – 16 Places That Take What Toy Drives Won’t

November 16, 2026
Full Episode: TODAY Show – Nov. 2

Full Episode: TODAY Show – Nov. 2

November 12, 2026
Data center fear: Overreaction or justified? AI trade: Still early or getting overheated?

Data center fear: Overreaction or justified? AI trade: Still early or getting overheated?

November 9, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!